severe obesity
Endocrinology · 2006–2022
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| semaglutide Treatment of severe obesity in adults with BMI ≥35 kg/m² and at least one weight-related comorbidity but without type 2 diabetes. | Mar 2022 | Not recommended | 27 individuals Diabetes Australia · Weight Issues Network |
| sibutramine hydrochloride Treatment of severe obesity (BMI ≥35 kg/m²) with two or more risk factors including Type 2 diabetes, adequately controlled hypertension, elevated… | Mar 2006 | Not recommended | no section in document |
| sibutramine hydrochloride Treatment of severe obesity (BMI ≥ 35 kg/m²) in the presence of two or more risk factors (Type 2 diabetes, hypertension, high triglycerides, or low HDL). | Mar 2006 | Not recommended | no section in document |
| sibutramine hydrochloride Management of severe obesity (BMI > 35 kg/m²) in adults aged 18–65 years with two or more risk factors (Type 2 diabetes, high triglycerides, or low HDL), in… | Nov 2006 | Not recommended | no section in document |
| sibutramine hydrochloride Management of severe obesity (BMI > 35 kg/m²) in adults aged 18–65 years with multiple risk factors (Type 2 diabetes, high triglycerides, or low HDL… | Nov 2006 | Not recommended | no section in document |
Who spoke
Diabetes Australia · Weight Issues Network
What the PBS pays
$260M in government benefit over 2024–25, across 2,176,978 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| semaglutide | $260.5M |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.